DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 2Taro Pharmaceutical Industries
03 1Breckenridge Pharmaceutical
04 2NanoAlvand
05 1Ajanta Pharma Limited
06 2Auro Pharma Inc
07 1Aurobindo Pharma Limited
08 2Bluepharma
09 3DelNova Healthcare
10 3Farmaprojects S.A.U
11 1Hikma Pharmaceuticals
12 2Intas Pharmaceuticals
13 1JAMP PHARMA
14 2Laboratorio Eczane Pharma
15 2MSN Laboratories
16 1Micro Labs Limited
17 17Pfizer Consumer Healthcare
18 11Pfizer Inc
19 1Pharmascience Inc.
20 3Pluviaendo
21 1Prinston
22 2Pulse Pharmaceuticals
23 1Unichem Laboratories Limited
24 2Yaopharma
25 3Zydus Pharmaceuticals
01 3Extended Release Tablet
02 1FCT
03 3Film Coated Tablet
04 1Film Coated XR Tablet
05 1Filmtabl
06 1Filmtablet
07 2IR Film Coated Tablet
08 1Oral Solid Dosage Form
09 1Oral Solution
10 2SOLUTION;ORAL
11 2SR Tablet
12 1Sustained Release Tablet
13 8TABLET
14 1TABLET (EXTENDED-RELEASE)
15 5TABLET, EXTENDED RELEASE;ORAL
16 11TABLET;ORAL
17 7Tablet
18 12tablet
19 5Blank
01 6DISCN
02 1Generic
03 1Lead Market Dossiers- Under Development
04 1Originator
05 9Prescription
06 6RX
07 44Blank
01 2AURO-TOFACITINIB
02 1JAMP TOFACITINIB
03 1PMS-TOFACITINIB
04 2Rhofanib
05 2TARO-TOFACITINIB
06 7TOFACITINIB
07 4TOFACITINIB CITRATE
08 2Tofacitinib
09 2Tofax
10 1Tofaxen 11 XR
11 1Tofaxen 5
12 5XELJANZ
13 5XELJANZ XR
14 20Xeljanz
15 1Xeljanz 5 mg
16 12Blank
01 2Argentina
02 17Australia
03 9Canada
04 9India
05 2Iran
06 2Portugal
07 1South Africa
08 3Spain
09 2Switzerland
10 3Turkey
11 18USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 22MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 209633
Regulatory Info :
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Rhofanib
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : Prescription
Registration Country : Canada
TOFACITINIB (TOFACITINIB CITRATE)
Brand Name : TARO-TOFACITINIB
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 2511304
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
TOFACITINIB (TOFACITINIB CITRATE)
Brand Name : TARO-TOFACITINIB
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 2511312
Regulatory Info : Prescription
Registration Country : Canada
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Rhofanib
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2021-06-01
Application Number : 212943
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : SOLUTION;ORAL
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2023-09-25
Application Number : 216878
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2023-03-13
Application Number : 209738
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2012-11-06
Application Number : 203214
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2018-05-30
Application Number : 203214
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 11MG BASE
Packaging :
Approval Date : 2016-02-23
Application Number : 208246
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 22MG BASE
Packaging :
Approval Date : 2019-12-12
Application Number : 208246
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ
Dosage Form : SOLUTION;ORAL
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2020-09-25
Application Number : 213082
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 209923
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Tofacitinib
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 215552
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Tofacitinib
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 215552
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2023-03-13
Application Number : 209829
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 11MG BASE
Packaging :
Approval Date : 2021-08-19
Application Number : 214264
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 22MG BASE
Packaging :
Approval Date : 2021-08-19
Application Number : 214264
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?
